Newsletter | September 15, 2026

09.15.26 -- Fixing AAV Recovery With Siren Biotechnology's Nathalie Clément, Ph.D.

SPONSOR

 

Webinar: Evaluating Modular CAR T Manufacturing Workflows: Performance, Flexibility, and Scale

Join this webinar to explore how modular workflows can help CAR T developers increase manufacturing flexibility, throughput, and scalability while maintaining critical cell quality attributes. Review comparative data across activation, transduction, phenotype, and cell isolation, and learn how modular strategies can enable parallel processing, reduce bottlenecks, and support evolving manufacturing requirements from process development through commercial production. Click here to learn more.

The Truth About End-To-End Manufacturing Automation

Webinar | Invetech

Discover how automation, modular design, and real-time analytics are transforming cell and gene therapy manufacturing to unlock scalable, cost-effective production without compromising quality.

Magnetic Separation System For More Pure Cell Isolation

Video | Thermo Fisher Scientific

Ready to achieve high-purity results in your cell therapy manufacturing? This step-by-step guide demonstrates the complete setup and installation for your automated magnetic cell isolation system and kit.

 

In Vivo CAR-T And Gene Editing: Manufacturing Reality Behind The Promise

Webinar | Lonza

Gain practical insights into the manufacturing realities shaping in vivo CAR-T development and learn how leading teams are addressing the challenges of scaling both LNP and viral vector platforms.

Controlled-Rate Freezing Studies For Single-Use Materials

Video | Charter Medical

Controlled-rate freezing studies stress single-use materials to reveal critical data on how advanced therapies perform at ultra-low temperatures during cryopreservation.

Fixing AAV Recovery With Siren Biotechnology's Nathalie Clément, Ph.D.

Video | Bioprocess Online

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Nathalie Clément, Ph.D., Siren Biotechnology’s SVP of vector development, to discuss the historical challenges of purifying AAV vectors and the developments that have allowed for greater product yields.

U.S. Payer Insights To Accelerate Commercial CGT Market Access

Webinar | Cencora

Payer interviews reveal key coverage processes, evidence demands, and engagement strategies needed to accelerate commercial market access from late-stage development.

Connect With Cell & Gene: